University of Rochester, Site 137 — Rochester, New York

University of Rochester, Site 137 is a clinical research site located in Rochester, New York, United States 14627.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

University of Rochester, Site 137 has participated in 1 clinical trials.

Therapeutic areas: Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL).

Sponsors: Ariad Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Rochester, Site 137?

University of Rochester, Site 137 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Rochester, Site 137 conducted?

University of Rochester, Site 137 has 1 clinical trials on record. Their work covers Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL).

Is University of Rochester, Site 137 accredited by Crixeo Health?

University of Rochester, Site 137 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Rochester, Site 137?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.